跳至主要内容
临床试验/NCT03823742
NCT03823742已完成不适用

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

Baylor College of Medicine4 个研究点 分布在 1 个国家目标入组 163 人开始时间: 2019年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
163
试验地点
4
主要终点
Symptom Improvement

研究概览

简要总结

The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

详细描述

AIM 1: We will categorize children ages 7-12 yrs. of age with FGIDs (n=250) as to whether they have/do not have one or more of the following abnormal physiologic changes: a) Autonomic Nervous System imbalance as indicated by low heart rate variability; and/or (b) Abnormalities in gut physiology: Impaired gut barrier function (increased permeability); and/or increased abundance of species of Gammaproteobacteria and/or Clostridia; and/or Gut neuroimmune dysfunction (increased fecal chromogranin A and secretogranin 2 concentrations).

AIM 2: Children will be randomized to the two treatments most commonly used in clinical practice: CBT or a low FODMAP diet for a 3-week treatment period. We will compare the response to the treatments in those with/without abnormal physiologic biomarkers at 3 weeks, 3 months, and 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
7 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • A child 7-12 years of age with a FGID will be recruited if the medical evaluation reveals no organic reason for the abdominal pain and the child has abdominal pain that meets the definition of a FGID (i.e., IBS, functional abdominal pain) according to the pediatric Rome III criteria (Rome IV will be substituted when validated). Parents and children must speak and understand English because of the psychological assessment and CBT requirements.

排除标准

  • Children who have: had past bowel surgery; documented GI disorders (e.g., Crohn's disease); a serious chronic medical condition (e.g., diabetes); weight and/or height < 2 SD for age; chronic conditions with GI symptoms (e.g., cystic fibrosis); autism spectrum disorder, significant developmental delay, psychosis, or a history of bipolar disorder; been treated with antibiotics/probiotics within 2 mo. (because of effects on gut microbiome analysis), and children who for some reason could not be randomized to the low FODMAP diet.Vegetarian; children who are currently on the FODMAP Diet or receiving CBT Children who speak only Spanish are not eligible because the Rome questionnaire and psychological testing are not available in Spanish. Despite this, a large proportion of the children enrolled will be Hispanic.

结局指标

主要结局

Symptom Improvement

时间窗: 3 to 4 weeks

Abdominal pain frequency or severity

次要结局

  • Improvement in quality of life(6 months)
  • Symptom Improvement(6 months)
  • Improvement in quality of life(3 months)
  • Symptom Improvement(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Shulman, M.D.

Professor

Baylor College of Medicine

研究点 (4)

Loading locations...

相似试验